Longterm followup and quality of life after hematopoietic stem cell transplantation

Journal of Rheumatology

Volumn 24, Issue SUPPL. 48, 1997, Pages 46-52

  Sullivan, Keith M ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoimmune disease; Graft versus host disease; Hematopoietic stem cell transplantation; Quality of life

Indexed keywords

ADULT; AUTOIMMUNE DISEASE; CHRONIC DISEASE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SECOND CANCER; SURVIVAL RATE; AUTOIMMUNITY; CANCER RISK; CATARACT; CONFERENCE PAPER; ENDOCRINE DISEASE; GONAD DYSFUNCTION; GYNECOLOGIC DISEASE; HEMATOLOGIC DISEASE; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; THERAPY; WHOLE BODY RADIATION;

ADULT; AUTOIMMUNE DISEASES; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING;

AZATHIOPRINE; BUSULFAN; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; PREDNISONE; TACROLIMUS; THALIDOMIDE; URSODEOXYCHOLIC ACID;

EID: 0030976164     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sullivan KM, Mori M, Sanders J, et al: Late complications of allogeneic and autologous transplantation. Bone Marrow Transplant 1992;10:127-34.
2. Bush NE, Haberman M, Donaldson G, Sullivan KM: Quality of life in 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med 1995;40:479-90.
3. Sullivan KM, World Transplant Records: Bone Marrow and Peripheral Blood. In: Cecka JM, Terasak PI, eds. Clinical Transplants 1995. Los Angeles: UCLA Tissue Typing Laboratory, Los Angeles, 1995:549-59.
4. Benyunes MC, Sullivan KM, Deeg HJ, et al: Cataracts after bone marrow transplant: Long-term follow-up of adults with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 1995;32:661-70.
5. Thomas ED, Clift RA, Hersman J, et al: Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation. Int J Radiat Oncol Biol Phys 1982;8:817-21.
6. Bearman SI, Appelbaum FR, Buckner CD, et al: Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988;6:1562-8.
7. Sanders JE and the Long-term Follow-up Team: Endocrine problems in children after bone marrow transplant for hematologic malignancies. Bone Marrow Transplant 1991;(suppl 1)8:2-4.
8. Sklar CA, Kim TH, Ramsay NKC: Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 1982;73:688-94.
9. Lio S, Arcese W, Papa G, D'Armiento M: Thyroid and pituitary function following allogeneic bone marrow transplant. Arch Int Med 1988;148:1066-71.
10. Sanders JE, and the Seattle Marrow Transplant Team: The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 1991;28:244-9.
11. Wingard JR, Plotnick LP, Freemer CS, et al: Growth in children after bone marrow transplantation: Busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992;79:1068-73.
12. Sanders JE: Growth and development after bone marrow transplant. In: Forman SJ, Blume KJ, Thomas ED, eds. Bone marrow transplantation. Boston: Blackwell Scientific, 1994:527-37.
13. Sanders JE, Pritchard S, Mahoney P, et al: Growth and development following marrow transplantation for leukemia. Blood 1986;68:1129-35.
14. Sanders JE, Buckner CD, Amos D, et al: Ovarian function following marrow transplantation for aplastic anemia of leukemia. J Clin Oncol 1988;6:813-8.
15. Sanders JE, Buckner CD, Leonard JM, et al: Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 1983;36:252-5.
16. Schubert MA, Sullivan KM, Schubert MM, et al: Gynecological abnormalities following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990;5:425-30.
17. Hinterberger-Fischer M, Kier P, Kalhs P, et al: Fertility, pregnancies and offspring complications after bone marrow transplantation. Bone Marrow Transplant 1991;7:5-9.
18. Sanders JE, Hawley J, Levy W, et al: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total body irradiation and bone marrow transplantation. Blood 1996;87:3045-52.
19. Witherspoon RP, Lum LG, Storb R: Immunologic reconstitution after human marrow grafting. Semin Hematol 1984;21:2-10.
20. Olsen GA, Gockerman JP, Bast RC Jr, Borowitz M, Peters WP: Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow support. Transplantation 1988;46:57-60.
21. Atkinson K, Farwell V, Storb R, et al: Analysis of late infections after human bone marrow transplantation: Role of genotypic non-identity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 1982;60:714-20.
22. Paulin T, Ringdén O, Nilsson B: Immunological recovery after bone marrow transplantation: Role of age, graft-versus-host disease, prednisolone treatment and infections. Bone Marrow Transplant 1987;1:317-28.
23. Aucouturier P, Barra A, Intrator L, et al: Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987;70:779-85.
24. Sullivan KM, Kopecky KJ, Jocom J, et al: Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990;323:705-12.
25. Bass EB, Powe NR, Goodman SN, et al: Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis. Bone Marrow Transplant 1993;12:273-82.
26. Agosti JM, Sprenger JD, Lum LG, et al: Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988;319:1623-8.
27. Ljungman P, Fridell E, Lönnquist B, et al: Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989;159:610-5.
28. Atkinson K, Storb R, Prentice RL, et al: Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979;53:720-31.
29. Locksley RM, Flournoy N, Sullivan KM, Meyers JD: Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985;152:1172-81.
30. Schuchter L, Wingard J, Piantadosi S, et al: Herpes zoster infection after autologous bone marrow transplantation. Blood 1989;74:1424-7.
31. Sullivan KM, Agura E, Anasetti C, et al: Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991;28:250-9.
32. Sullivan KM, Shulman HM, Storb R, et al: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981;57:267-76.
33. Sullivan KM, Witherspoon RP, Storb R, et al: Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988;72:546-54.
34. Sullivan KM, Witherspoon RP, Storb R, et al: Alternating-day cyclosporine and prednisone for treatment of high-risk graft-versus-host disease. Blood 1988;72:555-61.
35. Vogelsang GB, Farmer ER, Hess AD, et al: Thalidomide for the treatment of chronic graft versus host disease. N Engl J Med 1992;326:1055-8.
36. Parker PM, Chao N, Nademanee A, et al: Thalidomide as salvage therapy for chronic graft-versus-host disease. Blood 1995;86:3604-9.
37. Fried RH, Murakami CS, Fisher LD, Willson RA, Sullivan KM, McDonald GB: Ursodeoxycholic acid treatment of refractory chronic graft-versus-host of the liver. Ann Intern Med 1992;116:624-9.
38. Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW: Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988;72:621-7.
39. Sullivan KM, Storek J, Kopecky KJ, et al: A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-versus-host disease following marrow transplantation: Clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant 1996;2:44-53.
40. Witherspoon RP, Fischer L, Schoch G, et al: Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989;321:784-9.
41. Witherspoon RP, Storb R, Pepe M, Longton G, Sullivan KM: Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone (letter). Blood 1992;79:289.
42. Socié G, Henry-Amar M, Bacigalupo A, et al: Malignant tumor occurring after treatment of aplastic anemia. N Engl J Med 1993;329:1152-7.
43. Deeg HJ, Socié G, Schoch G, et al: Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 1996;87:386-92.
44. Andrykowski MA, Altmaier EM, Barnett RL, Otis ML, Gingrich R, Henslee-Downey PJ: The quality of life in adult survivors of allogeneic bone marrow transplantation. Transplantation 1990;50:399-406.
45. Wingard JR, Curbow B, Baker F, Piantadosi S: Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Intern Med 1991;114:113-8.
46. Chao NJ, Tierney DK, Bloom JR, et al: Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood 1992;80:825-30.
47. Wingard JR, Curbow B, Gaker F, Zabora J, Piantadosi S: Sexual satisfaction in survivors of bone marrow transplantation. Bone Marrow Transplant 1992;9:185-90.
48. Schmidt GM, Niland JC, Forman SJ, et al: Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of life. Transplantation 1993;55:551-7.
49. Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM: Recovery after allogeneic marrow transplantation: Prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993;11:319-27.
50. Sullivan KM, Walters MC, Patience M, et al: Collaborative study of marrow transplantation for sickle cell disease: Aspects specific for transplantation of hemoglobin disorders. Bone Marrow Transplant (in press).